Blood Velocity Variation in Right Renal and Superior Mesenteric Arteries During Cardio-pulmonary Bypass

November 27, 2025 updated by: Dr.ssa Gabriella Arlotta, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
The cardiopulmonary by-pass technique, used in cardiac surgery to obtain a bloodless operating field and an immobile heart, determines important effects on the blood vessel wall, especially when a continuous and non-continuous blood flow is used. In fact, a reduction in Nitric Oxide (NO) production by the endothelium, an increase in systemic vascular resistance and an increased risk of cerebral and renal hypoperfusion have been observed and can result in potential organ damage. Acute kidney injury (AKI) after heart surgery is a major cause of mortality and morbidity. Its incidence varies according to different definitions, but can reach 30%. In some series, 1-5% of patients require renal replacement therapy in the postoperative period presenting a mortality that can reach 50-70%. However, even more limited increases in serum creatinine are associated with worsening prognosis and the risk of chronic kidney disease. The pathophysiology of AKI in cardiac surgery is complex and still partly unknown.Recently a technique has been described that allows to measure the blood velocity in the right renal artery and in the superior mesenteric artery using the transesophageal echocardiogram (TEE); this technique allows to view these arteries and measure the speed of the blood with good precision because the insonation angle (ie the angle formed by the ultrasound flow and the direction of the blood vessel) is adequate. In cardiac surgery, this methodology allows you to monitor blood velocity in the right renal artery and superior mesenteric artery during surgery. Some authors have used it to conduct pilot studies in which the blood velocity values in the renal arteries during cardiac surgery were used to calculate the pulsatility and resistivity indices, as predictors of the risk of postoperative AKI. At present, therefore, despite the fact that TEE is routinely used for monitoring renal perfusion during cardiac surgery, the blood velocity in the renal and mesenteric arteries has been little studied during cardiopulmonary by-pass (CPB) and has never been evaluated during CPB with continuous flow; in particular, the possible variation in blood velocity measured during CPB compared to the baseline values measured before extracorporeal circulation and its correlation with the onset of postoperative renal failure is not known.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

The cardiopulmonary by-pass (CPB) technique, used in cardiac surgery to obtain a bloodless operating field and an immobile heart, determines important effects on the blood vessel wall, especially when a continuous and non-continuous blood flow is used. In fact, a reduction in NO production by the endothelium, an increase in systemic vascular resistance and an increased risk of cerebral and renal hypoperfusion have been observed and can result in potential organ damage.

Acute kidney injury (AKI) after heart surgery is a major cause of mortality and morbidity. Its incidence varies according to different definitions, but can reach 30%. In some series, 1-5% of patients require renal replacement therapy (RRT) in the postoperative period presenting a mortality that can reach 50-70%. However, even more limited increases in serum creatinine (sCr) are associated with worsening prognosis and the risk of chronic kidney disease (CKD). The pathophysiology of AKI in cardiac surgery is complex and still partly unknown. It is believed that one of the main causative factors is hypoperfusion and renal hypoxia, in particular of the medullary region; this would result in a vasoconstriction of the afferent arterioles to the glomerulus and a reduction in filtration. Risk factors associated with the increased incidence of AKI include bleeding, use of the aortic pump, excessive cardiopulmonary bypass duration, excessive haemodilution, insufficient pump flow, or insufficient blood pressure. Hypothermia, which also has a protective effect against hypoperfusion and tissue hypoxia, could induce AKI by increasing renal vascular resistance and favoring medullary hypoxia during subsequent rewarming.

In addition to AKI, another complication of cardiac surgery, rarer but associated with a higher mortality, is acute mesenteric ischemia; the most frequent type is non-occlusive mesenteric ischemia (NOMI) which seems to have as a predisposing cause a reduction or maldistribution of splanchnic blood flow and the use of vasoconstrictors.

Recently a technique has been described that allows to measure the blood velocity in the right renal artery and in the superior mesenteric artery using the transesophageal echocardiogram (TEE); this technique allows to view these arteries and measure the speed of the blood with good precision because the insonation angle (ie the angle formed by the ultrasound flow and the direction of the blood vessel) is adequate. In cardiac surgery, this methodology allows you to monitor blood velocity in the right renal artery and superior mesenteric artery during surgery. Some authors have used it to conduct pilot studies in which the blood velocity values in the renal arteries during cardiac surgery were used to calculate the pulsatility and resistivity indices, as predictors of the risk of postoperative AKI. The calculation of these indices, however, requires the use of a pulsatile blood flow to generate a periodic variation of the blood velocity, and they are not evaluable during CPB since the current practice in almost all centers is to use a continuous blood flow. At present, therefore, despite the fact that TEE is routinely used for monitoring renal perfusion during cardiac surgery, the blood velocity in the renal and mesenteric arteries has been little studied during CPB and has never been evaluated during CPB with continuous flow; in particular, the possible variation in blood velocity measured during CPB compared to the baseline values measured before extracorporeal circulation and its correlation with the onset of postoperative renal failure is not known.

Study Type

Observational

Enrollment (Estimated)

92

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

The study will enroll patients of both sexes, aged> 18 years, with cardiovascular disease, who must undergo cardiac surgery in extracorporeal circulation with continuous flow

Description

Inclusion Criteria:

  • age> 18 years
  • written informed consent
  • cardiac surgery with cardiopulmonary bypass (CPB)
  • New York Heart Association (NYHA) class I, II, III
  • preoperative serum creatinine less than 1.2 mg / dl

Exclusion Criteria:

  • contraindications to Trans Esophageal Ultrasound (TEE) based on American Society of Anesthesiologists (ASA) recommendations (esophageal or gastric diseases or previous surgery)
  • history of non-coronary arterial pathologies
  • atrial fibrillation
  • preoperative serum creatinine greater than 1.2 mg / dl • NYHA class IV
  • emergency cardiac surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Heart Surgical Patients
Patients with cardiovascular disease, who must undergo cardiac surgery in extracorporeal circulation with continuous flow
To measure mean blood velocity at the level of the right renal and superior mesenteric artery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of right renal artery mean blood velocities before and during cardiopulmonary by-pass (CPB)
Time Frame: Basal 1: up to 10 minutes after induction of anesthesia and placement of transesophageal probe
Right renal artery mean blood velocity (cm/sec) before CPB
Basal 1: up to 10 minutes after induction of anesthesia and placement of transesophageal probe
Comparison of right renal artery mean blood velocities before and during cardiopulmonary by-pass (CPB)
Time Frame: Basal 2: up to 30 minutes after sternotomy in conditions of hemodynamic stability
Right renal artery mean blood velocity (cm/sec) before CPB
Basal 2: up to 30 minutes after sternotomy in conditions of hemodynamic stability
Comparison of right renal artery mean blood velocities before and during cardiopulmonary by-pass (CPB)
Time Frame: CPB 5 min: during CPB, 5 minutes after the end of the first cardioplegia
Right renal artery mean blood velocity (cm/sec) during CPB
CPB 5 min: during CPB, 5 minutes after the end of the first cardioplegia
Comparison of right renal artery mean blood velocities before and during cardiopulmonary by-pass (CPB)
Time Frame: CPB 30 min: during CPB, 30 minutes after the end of the first cardioplegia
Right renal artery mean blood velocity (cm/sec) during CPB
CPB 30 min: during CPB, 30 minutes after the end of the first cardioplegia
Comparison of right renal artery mean blood velocities before and during cardiopulmonary by-pass (CPB)
Time Frame: CPB 60 min: during CPB, 60 minutes after the end of the first cardioplegia
Right renal artery mean blood velocity (cm/sec) during CPB
CPB 60 min: during CPB, 60 minutes after the end of the first cardioplegia

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of superior mesenteric artery mean blood velocities before and during cardiopulmonary by-pass (CPB)
Time Frame: Basal 1: up to 10 minutes after induction of anesthesia and placement of transesophageal probe
Superior mesenteric artery mean blood velocity (cm/sec) before CPB
Basal 1: up to 10 minutes after induction of anesthesia and placement of transesophageal probe
Comparison of superior mesenteric artery mean blood velocities before and during cardiopulmonary by-pass (CPB)
Time Frame: Basal 2: up to 30 minutes after sternotomy in conditions of hemodynamic stability
Superior mesenteric artery mean blood velocity (cm/sec) before CPB
Basal 2: up to 30 minutes after sternotomy in conditions of hemodynamic stability
Comparison of superior mesenteric artery mean blood velocities before and during cardiopulmonary by-pass (CPB)
Time Frame: CPB 5 min: during CPB, 5 minutes after the end of the first cardioplegia
Superior mesenteric artery mean blood velocity (cm/sec) during CPB
CPB 5 min: during CPB, 5 minutes after the end of the first cardioplegia
Comparison of superior mesenteric artery mean blood velocities before and during cardiopulmonary by-pass (CPB)
Time Frame: CPB 30 min: during CPB, 30 minutes after the end of the first cardioplegia
Superior mesenteric artery mean blood velocity (cm/sec) during CPB
CPB 30 min: during CPB, 30 minutes after the end of the first cardioplegia
Comparison of superior mesenteric artery mean blood velocities before and during cardiopulmonary by-pass (CPB)
Time Frame: CPB 60 min: during CPB, 60 minutes after the end of the first cardioplegia
Superior mesenteric artery mean blood velocity (cm/sec) during CPB
CPB 60 min: during CPB, 60 minutes after the end of the first cardioplegia
Correlation between mean blood velocity values and hemodynamic parameters: cardiopulmonary by-pass (CPB) blood flow
Time Frame: CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
Correlation between right renal artery mean blood velocity (cm/sec) and CPB blood flow (L/min)
CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
Correlation between mean blood velocity values and CPB blood flow
Time Frame: CPB 30 min: 30 minutes after the end of the first cardioplegia, during CPB
Correlation between right renal artery mean blood velocity (cm/sec) and CPB blood flow (L/min)
CPB 30 min: 30 minutes after the end of the first cardioplegia, during CPB
Correlation between right renal artery mean blood velocity values and CPB blood flow
Time Frame: CPB 60 min: 60 minutes after the end of the first cardioplegia
Correlation between right renal artery mean blood velocity (cm/sec) and cardiopulmonary by-pass blood flow (L/min)
CPB 60 min: 60 minutes after the end of the first cardioplegia
Correlation between superior mesenteric artery mean blood velocity values and cardiopulmonary by-pass (CPB) blood flow
Time Frame: CPB 5 min: 5 minutes after the end of the first cardioplegia
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and cardiopulmonary by-pass blood flow (L/min)
CPB 5 min: 5 minutes after the end of the first cardioplegia
Correlation between superior mesenteric artery mean blood velocity values and CPB blood flow
Time Frame: CPB 30 min: 30 minutes after the end of the first cardioplegia, during cardiopulmonary by-pass
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and cardiopulmonary by-pass blood flow (L/min)
CPB 30 min: 30 minutes after the end of the first cardioplegia, during cardiopulmonary by-pass
Correlation between superior mesenteric artery mean blood velocity values and CPB blood flow
Time Frame: CPB 60 min: 60 minutes after the end of the first cardioplegia
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and cardiopulmonary by-pass blood flow (L/min)
CPB 60 min: 60 minutes after the end of the first cardioplegia
Correlation between right renal artery mean blood velocity values and hemodynamic parameters (mean arterial pressure, MAP)
Time Frame: CPB 5 min: 5 minutes after the end of the first cardioplegia
Correlation between right renal artery mean blood velocity (cm/sec) and mean arterial pressure (mmHg)
CPB 5 min: 5 minutes after the end of the first cardioplegia
Correlation between right renal artery mean blood velocity values and MAP
Time Frame: CPB 30 min: 30 minutes after the end of the first cardioplegia
Correlation between right renal artery mean blood velocity (cm/sec) and MAP (mmHg)
CPB 30 min: 30 minutes after the end of the first cardioplegia
Correlation between right renal artery mean blood velocity values and MAP
Time Frame: CPB 60 min: 60 minutes after the end of the first cardioplegia
Correlation between right arterial mean blood velocity (cm/sec) and mean arterial pressure (mmHg)
CPB 60 min: 60 minutes after the end of the first cardioplegia
Correlation between superior mesenteric artery mean blood velocity values and hemodynamic parameters (mean arterial pressure, MAP)
Time Frame: CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and MAP (mmHg)
CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
Correlation between superior mesenteric artery mean blood velocity values and MAP
Time Frame: CPB 30 min: 30 minutes after the end of the first cardioplegia
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and mean arterial pressure (mmHg)
CPB 30 min: 30 minutes after the end of the first cardioplegia
Correlation between superior mesenteric artery mean blood velocity values and MAP
Time Frame: CPB 60 min: 60 minutes after the end of the first cardioplegia
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and MAP (mmHg)
CPB 60 min: 60 minutes after the end of the first cardioplegia
Correlation between right renal artery mean blood velocity values and laboratory parameters (arterial PCO2)
Time Frame: CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
Correlation between right renal artery mean blood velocity (cm/sec) and arterial PCO2 (mmHg)
CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
Correlation between right renal artery mean blood velocity values and laboratory parameters (arterial PCO2)
Time Frame: CPB 30 min: 30 minutes after the end of the first cardioplegia
Correlation between right renal artery mean blood velocity (cm/sec) and arterial PCO2 (mmHg)
CPB 30 min: 30 minutes after the end of the first cardioplegia
Correlation between right renal artery mean blood velocity values and arterial PCO2
Time Frame: CPB 60 min: 60 minutes after the end of the first cardioplegia
Correlation between right renal artery mean blood velocity (cm/sec) and arterial PCO2 (mmHg)
CPB 60 min: 60 minutes after the end of the first cardioplegia
Correlation between superior mesenteric artery mean blood velocity values and laboratory parameters (arterial PCO2)
Time Frame: CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and arterial PCO2 (mmHg)
CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
Correlation between superior mesenteric artery mean blood velocity values and laboratory parameters (arterial PCO2)
Time Frame: CPB 30 min: 30 minutes after the end of the first cardioplegia
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and arterial PCO2 (mmHg)
CPB 30 min: 30 minutes after the end of the first cardioplegia
Correlation between superior mesenteric artery mean blood velocity values and arterial PCO2
Time Frame: CPB 60 min: 60 minutes after the end of the first cardioplegia
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and arterial PCO2 (mmHg)
CPB 60 min: 60 minutes after the end of the first cardioplegia
Correlation between right renal artery mean mean blood velocity values and laboratory parameters (Hematocrit)
Time Frame: CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
Correlation between right renal artery mean blood velocity (cm/sec) and hematocrit
CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
Correlation between right renal artery mean mean blood velocity values and laboratory parameters (Hematocrit)
Time Frame: CPB 30 min: 30 minutes after the end of the first cardioplegia
Correlation between right renal artery mean blood velocity (cm/sec) and hematocrit
CPB 30 min: 30 minutes after the end of the first cardioplegia
Correlation between right renal artery mean mean blood velocity values and laboratory parameters (Hematocrit)
Time Frame: CPB 60 min: 60 minutes after the end of the first cardioplegia
Correlation between right renal artery mean blood velocity (cm/sec) and hematocrit
CPB 60 min: 60 minutes after the end of the first cardioplegia
Correlation between superior mesenteric artery mean mean blood velocity values and laboratory parameters (Hematocrit)
Time Frame: CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and hematocrit
CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
Correlation between superior mesenteric artery mean mean blood velocity values and Hematocrit
Time Frame: CPB 30 min: 30 minutes after the end of the first cardioplegia
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and hematocrit
CPB 30 min: 30 minutes after the end of the first cardioplegia
Correlation between superior mesenteric artery mean mean blood velocity values and Hematocrit
Time Frame: CPB 60 min: 60 minutes after the end of the first cardioplegia
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and hematocrit
CPB 60 min: 60 minutes after the end of the first cardioplegia
Correlation between right renal artery mean blood velocity values and Temperature
Time Frame: CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
Correlation between right renal artery mean blood velocity (cm/sec) and Temperature (Celsius degrees)
CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
Correlation between right renal artery mean blood velocity values and Temperature
Time Frame: CPB 30 min: 30 minutes after the end of the first cardioplegia
Correlation between right renal artery mean blood velocity (cm/sec) and Temperature (Celsius degrees)
CPB 30 min: 30 minutes after the end of the first cardioplegia
Correlation between right renal artery mean blood velocity values and Temperature
Time Frame: CPB 60 min: 60 minutes after the end of the first cardioplegia
Correlation between right renal artery mean blood velocity (cm/sec) and Temperature (Celsius degrees)
CPB 60 min: 60 minutes after the end of the first cardioplegia
Correlation between superior mesenteric artery mean blood velocity values and Temperature
Time Frame: CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and Temperature (Celsius degrees)
CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
Correlation between superior mesenteric artery mean blood velocity values and Temperature
Time Frame: CPB 30 min: 30 minutes after the end of the first cardioplegia
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and Temperature (Celsius degrees)
CPB 30 min: 30 minutes after the end of the first cardioplegia
Correlation between superior mesenteric artery mean blood velocity values and Temperature
Time Frame: CPB 60 min: 60 minutes after the end of the first cardioplegia
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and Temperature (Celsius degrees9
CPB 60 min: 60 minutes after the end of the first cardioplegia
Correlation between right renal artery mean blood velocity values and negative pressure applied to the venous drainage (vacuum-assist venous drainage, VAVD)
Time Frame: CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
Correlation between right renal artery mean blood velocity (cm/sec) and negative pressure applied to the venous drainage (vacuum-assist venous drainage) (mmHg)
CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
Correlation between right renal artery mean blood velocity values and negative pressure applied to the venous drainage (vacuum-assist venous drainage, VAVD)
Time Frame: CPB 30 min: 30 minutes after the end of the first cardioplegia
Correlation between right renal artery mean blood velocity (cm/sec) and VAVD (mmHg)
CPB 30 min: 30 minutes after the end of the first cardioplegia
Correlation between right renal artery mean blood velocity values and negative pressure applied to the venous drainage (vacuum-assist venous drainage, VAVD)
Time Frame: CPB 60 min: during CPB, 60 minutes after the end of the first cardioplegia
Correlation between right renal artery mean blood velocity (cm/sec) and VAVD (mmHg)
CPB 60 min: during CPB, 60 minutes after the end of the first cardioplegia
Correlation between superior mesenteric artery mean blood velocity values and negative pressure applied to the venous drainage (vacuum-assist venous drainage, VAVD)
Time Frame: CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
Correlation between superior mesenteric artery mean blood velocity values and negative pressure applied to the venous drainage (vacuum-assist venous drainage, VAVD) (mmHg)
CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
Correlation between superior mesenteric artery mean blood velocity values and negative pressure applied to the venous drainage (vacuum-assist venous drainage, VAVD)
Time Frame: CPB 30 min: 30 minutes after the end of the first cardioplegia
Correlation between superior mesenteric artery mean blood velocity values and negative pressure applied to the venous drainage (vacuum-assist venous drainage, VAVD) (mmHg)
CPB 30 min: 30 minutes after the end of the first cardioplegia
Correlation between superior mesenteric artery mean blood velocity values and negative pressure applied to the venous drainage (vacuum-assist venous drainage, VAVD)
Time Frame: CPB 60 min: 60 minutes after the end of the first cardioplegia
Correlation between superior mesenteric artery mean blood velocity values and VAVD (mmHg)
CPB 60 min: 60 minutes after the end of the first cardioplegia
Correlation between right renal artery mean blood velocity values and laboratory parameters (arterial lactate)
Time Frame: CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
Correlation between right renal artery mean blood velocity (cm/sec) and arterial lactate (mmol/L)
CPB 5 min: 5 minutes after the end of the first cardioplegia, during CPB
Correlation between right renal artery mean blood velocity values and laboratory parameters (arterial lactate)
Time Frame: CPB 30 min: 30 minutes after the end of the first cardioplegia
Correlation between right renal artery mean blood velocity (cm/sec) and arterial lactate (mmol/L)
CPB 30 min: 30 minutes after the end of the first cardioplegia
Correlation between right renal artery mean blood velocity values and laboratory parameters (arterial lactate)
Time Frame: CPB 60 min: 60 minutes after the end of the first cardioplegia
Correlation between right renal artery mean blood velocity (cm/sec) and arterial lactate (mmol/L)
CPB 60 min: 60 minutes after the end of the first cardioplegia
Correlation between superior mesenteric artery mean blood velocity and laboratory parameters (arterial lactate)
Time Frame: CPB 5 min: during CPB, 5 minutes after the end of the first cardioplegia
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and arterial lactate (mmol/L)
CPB 5 min: during CPB, 5 minutes after the end of the first cardioplegia
Correlation between superior mesenteric artery mean blood velocity and laboratory parameters (arterial lactate)
Time Frame: CPB 30 min: during CPB, 30 minutes after the end of the first cardioplegia
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and arterial lactate (mmol/L)
CPB 30 min: during CPB, 30 minutes after the end of the first cardioplegia
Correlation between superior mesenteric artery mean blood velocity and laboratory parameters (arterial lactate)
Time Frame: CPB 60 min: during CPB, 60 minutes after the end of the first cardioplegia
Correlation between superior mesenteric artery mean blood velocity (cm/sec) and arterial lactate (mmol/L)
CPB 60 min: during CPB, 60 minutes after the end of the first cardioplegia
Correlation between right renal artery mean blood velocity values during CPB and Acute Kidney Injury (AKI)
Time Frame: CPB 5 min: during CPB, 5 minutes after the end of the first cardioplegia
Comparison between right renal artery mean blood velocity (cm/sec) measured during CPB in patients who develop AKI according Kidney Disease Improving Global Outcomes (KDIGO) definition (AKI group) and in patients who don't develop AKI (non AKI group) during the postoperative period
CPB 5 min: during CPB, 5 minutes after the end of the first cardioplegia
Correlation between right renal artery mean blood velocity values during CPB and Acute Kidney Injury (AKI)
Time Frame: CPB 30 min: during CPB, 30 minutes after the end of the first cardioplegia
Comparison between right renal artery mean blood velocity (cm/sec) measured during CPB in patients who develop AKI according KDIGO definition (AKI group) and in patients who don't develop AKI (non AKI group) during the postoperative period
CPB 30 min: during CPB, 30 minutes after the end of the first cardioplegia
Correlation between right renal artery mean blood velocity values during CPB and Acute Kidney Injury (AKI)
Time Frame: CPB 60 min: during CPB, 60 minutes after the end of the first cardioplegia
Comparison between right renal artery mean blood velocity (cm/sec) measured during CPB in patients who develop AKI according KDIGO definition (AKI group) and in patients who don't develop AKI (non AKI group) during the postoperative period
CPB 60 min: during CPB, 60 minutes after the end of the first cardioplegia
Evaluation of serum Cystatin C in low right renal artery mean blood velocity during CPB
Time Frame: Postoperative day 1: 24 hours after the end of the cardiopulmonary by-pass
Comparison between serum Cystatin C mean level (mg/L) measured in patients with low (below the 25th percentile) and in patients with higher (above 25th percentile) right renal artery blood velocity (cm/sec) measured during CPB
Postoperative day 1: 24 hours after the end of the cardiopulmonary by-pass
Evaluation of urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL) in low right renal artery mean blood velocity
Time Frame: Immediate postoperative period: 4 hours after the end of the cardiopulmonary by-pass
Comparison between urinary uNGAL mean level (ng/ml) measured immediately after surgery in patients with low (below the 25th percentile) and in patients with higher (above 25th percentile) right renal artery blood velocity (cm/sec) during CPB
Immediate postoperative period: 4 hours after the end of the cardiopulmonary by-pass
Evaluation of urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL) in low right renal artery mean blood velocity
Time Frame: Postoperative day 1: 24 hours after the end of the cardiopulmonary by-pass
Comparison between urinary uNGAL mean level (ng/ml) measured on the first postoperative day in patients with low (below the 25th percentile) and in patients with higher (above 25th percentile) right renal artery blood velocity (cm/sec) during CPB
Postoperative day 1: 24 hours after the end of the cardiopulmonary by-pass
Evaluation of lactate in patients with low superior mesenteric artery mean blood velocity values
Time Frame: Immediate postoperative period: 4 hours after the end of the cardiopulmonary by-pass
Comparison between mean arterial lactate (mmol/L) measured immediately after surgery in patients with low (below the 25th percentile) and in patients with higher (above 25th percentile) superior mesenteric artery blood velocity (cm/sec) during CPB
Immediate postoperative period: 4 hours after the end of the cardiopulmonary by-pass
Evaluation of lactate in patients with low superior mesenteric artery mean blood velocity
Time Frame: Postoperative day 1: 24 hours after the end of the cardiopulmonary by-pass
Comparison between arterial lactate (mmol/L) measured on the first postoperative day in patients with low (below the 25th percentile) and in patients with higher (above 25th percentile) superior mesenteric artery mean blood velocity (cm/sec) measured during CPB
Postoperative day 1: 24 hours after the end of the cardiopulmonary by-pass
Evaluation of amylase in low superior mesenteric artery mean blood velocity
Time Frame: Immediate postoperative period: 4 hours after the end of the cardiopulmonary by-pass
Comparison between mean serum amylase (UI/L) measured immediately after surgery in patients with low (below the 25th percentile) and in patients with higher (above 25th percentile) superior mesenteric artery blood velocity (cm/sec) measured during CPB
Immediate postoperative period: 4 hours after the end of the cardiopulmonary by-pass
Evaluation of amylase in low superior mesenteric artery mean blood velocity
Time Frame: Postoperative day 1: 24 hours after the end of the cardiopulmonary by-pass
Comparison between mean serum amylase (UI/L) measured on the first postoperative day in patients with low (below the 25th percentile) and in patients with higher (above 25th percentile) superior mesenteric artery blood velocity (cm/sec) measured during CPB
Postoperative day 1: 24 hours after the end of the cardiopulmonary by-pass
Feasibility of measurement of right renal artery blood velocity during CPB
Time Frame: During CPB
the number of patients in whom is possible to measure right renal artery blood velocity during CPB
During CPB
Feasibility of measurement of superior mesenteric artery blood velocity during CPB
Time Frame: During CPB
the number of patients in whom is possible to measure superior mesenteric artery blood velocity during CPB
During CPB

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Chair: Cavaliere Franco, M.D., Fondazione Policlinico Agostino Gemelli IRRCS

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 15, 2022

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

May 26, 2022

First Submitted That Met QC Criteria

August 22, 2023

First Posted (Actual)

August 24, 2023

Study Record Updates

Last Update Posted (Actual)

December 1, 2025

Last Update Submitted That Met QC Criteria

November 27, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 4708

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Surgical Procedure

Clinical Trials on transesophageal echocardiogram

Search Similar Trials